MacroGenics sells rights to breast cancer drug; Rice’s new biotech accelerator

Plus, news about An­nex­on, Passkey Ther­a­peu­tics, XO­MA Roy­al­ty and Twist Bio­science:

Macro­Gen­ics sells breast can­cer drug rights for up to $75 mil­lion: The com­pa­ny is …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

October Cannabis Sales Dip

New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s monthly cannabis sales data for 11 states. Cannabis sales decreased 0.7% sequentially in October after

Read More »